Brief: Tivic Health Collaborates With Leading Medical Research Hospital On First Controlled Trial To Extend Tivic's Bioelectronic Platform
19/01/2022 14:59
Jan 19 (Reuters) - Tivic Health Systems Inc TIVC.O :
* TIVIC HEALTH COLLABORATES WITH LEADING MEDICAL RESEARCH HOSPITAL ON FIRST
CONTROLLED TRIAL TO EXTEND TIVIC'S BIOELECTRONIC PLATFORM
Source text for Eikon: ID:nBw4PqCBXa
Further company coverage: TIVC.O
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital